✦ LIBER ✦

Effect of treatment at night with S-1452, a thromboxane A2 receptor antagonist, on the morning rise in platelet aggregation

✍ Scribed by A. Fujimura; K. Kumagai; K. Ohashi; A. Ebihara

Publisher: Springer
Year: 1992
Tongue: English
Weight: 551 KB
Volume: 43
Category: Article
ISSN: 0031-6970
DOI: 10.1007/bf02285091

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Preventive effect of the thromboxane A2

Preventive effect of the thromboxane A2 receptor antagonist S-1452 (d-s-145 Ca) on arachidonate-induced sudden death and cerebral infarction in rabbits

✍ Hirokuni Jyoy; Atsushi Kurosawa 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 506 KB

The thromboxane A, (TXA,) receptor antagonist S-1452, d-S-145 Ca, calcium 5(Z)-1R,2S,3S, 4S-7-[3-phenylsulfonylaminobicyclo[2.2.llhept-2-yll-5-heptenoate dihydrate, prevented sudden death induced by arachidonate or U46619 in rabbits when given in a dose range between 0.1 mg/kg and 1 mg/kg, p.0. OKY-

The effect of ketanserin, a 5-HT2-recept

The effect of ketanserin, a 5-HT2-receptor antagonist, on 5-hydroxytryptamine-induced irreversible platelet aggregation in patients with cardiovascular diseases

✍ J. De Cree; J. Leempoels; B. Demoen; V. Roels; H. Verhaegen 📂 Article 📅 1985 🏛 SP Birkhäuser Verlag Basel 🌐 English ⚖ 402 KB